HIKAL.BO

Hikal Limited HIKAL.BO

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode HIKAL.BO IOLCP.BO IOLCP.NS MOREPENLAB.BO UNICHEMLAB.BO MOREPENLAB.NS UNICHEMLAB.NS SHILPAMED.BO VIMTALABS.BO ORCHPHARMA.NS
6M -43.00 % 40.08 % 40.04 % -10.21 % -26.26 % -10.15 % -26.49 % 9.66 % 37.14 % -9.74 %
YTD -40.02 % 15.10 % 15.19 % -38.97 % -36.40 % -38.83 % -36.63 % -55.79 % -30.70 % -60.68 %
1Y -34.76 % 16.44 % 16.51 % -41.08 % -38.61 % -40.98 % -38.52 % -56.33 % 21.97 % -45.02 %
3Y -26.06 % 31.40 % 31.42 % 77.83 % 11.66 % 78.42 % 20.52 % 123.53 % 72.39 % 104.20 %
5Y 40.91 % -30.06 % -29.99 % 80.15 % 11.66 % 80.75 % 89.32 % 52.67 % 368.55 % 3 910.28 %
10Y 163.97 % 487.41 % 489.12 % 179.11 % 11.66 % 180.00 % 59.43 % 44.78 % 720.51 % 3 910.28 %
Depuis le début 464.69 % 10 001.28 % 755.51 % -67.75 % 11.66 % 137.68 % 1 780.55 % 34 963.11 % 65 228.57 % 3 910.28 %

Dividende

Hikal Limited

IOL Chemicals and Pharmaceuticals Limited

IOL Chemicals and Pharmaceuticals Limited

Morepen Laboratories Limited

Unichem Laboratories Limited

Morepen Laboratories Limited

Unichem Laboratories Limited

Shilpa Medicare Limited

Vimta Labs Limited

Orchid Pharma Limited